跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,503 条关于
“COSMIC-312”
全部
5,503
临床试验
3,939
药物
1,023
机构
20
资讯
521
去年
CELESTIAL and COSMIC-312 Trials Shape Future of HCC Treatment Landscape
去年
Anlotinib Plus Penpulimab Shows Promise in Advanced Hepatocellular Carcinoma
去年
COSMIC-313 Trial: Triplet Therapy Shows Mixed Results in Advanced Renal Cell Carcinoma
6个月前
Tangram Therapeutics Initiates First-in-Human Trial of TGM-312 for MASH Treatment
去年
e-therapeutics' ETX-312 Shows Promise as Disease-Modifying MASH Treatment in Preclinical Studies
9个月前
Tangram Therapeutics Advances Novel RNAi Therapy TGM-312 to Clinical Trials for MASH Treatment
15天前
Tangram's TGM-312 Advances to MASH Patient Cohorts in Phase 1/2 RESTORE-MASH Trial
去年
Empyrean Therapeutics Acquires TLR-2 Antagonist EMS-312 from Eos Therapies to Advance Cancer Treatment
去年
Nanobiotix Transfers US Sponsorship of NANORAY-312 to Janssen, Anticipates Key Data Readouts
去年
Ultragenyx and Mereo BioPharma Advance Setrusumab Phase 3 Studies for Osteogenesis Imperfecta Toward Year-End Analysis
第 1 页,共 53 页
上一页
下一页